Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3107 results found
Expand All
Apply All
3107 results found

Biopharma groups pledge vaccine equity
Share
Good Day BIO Newsletter  •  May 19, 2021
Everyone’s talking about COVID vaccine equity—but what should we REALLY do to make it happen? We joined a commitment outlining five concrete steps. Meanwhile, we tell you what you need to watch in D.C. today and how you can support farmers and the planet. (762 words, 3 minutes, 48 seconds)
Read More

BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations
Share
Vaccines  •  Press Release  •  May 18, 2021
"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE” program, we’ve made clear the urgent need to strengthen and support healthcare systems in low-and middle-income countries in addressing COVID. The president’s decision to relinquish millions of doses is an important part of achieving this goal. “Going forward, we hope the administration will continue to look towards equity for global vaccine availability and distribution. Another great step would be to eliminate the financial contingencies which have been put in place which currently act as a barrier to COVAX. “BIO member companies have worked around the clock to find the scientific solutions we need to end this pandemic. We look forward to working with the White House to ensure people in every corner of the world have access to those solutions without damaging the premise of intellectual property on which this nation was built.”
Read More

U.S. will share 20 million vaccine doses with developing nations
Share
Good Day BIO Newsletter  •  May 18, 2021
The U.S. will donate an additional 20 million COVID vaccine doses to countries in need—read Dr. Michelle's response. Meanwhile, it's HIV Vaccine Awareness Day and we look at how COVID brought us one step closer to success, as well as DOE's new funding to advance biofuels and reduce carbon. (832 words, 4 minutes, 9 seconds)
Read More

BIO Joins Letter Supporting Chief Agricultural Negotiator at USTR
Share
Agriculture & Environment  •  Letters, Testimony & Comments  •  May 17, 2021
The undersigned food, agriculture, and seafood trade associations respectfully urge the expeditious nomination of the Chief Agricultural Negotiator at the Office of the U.S. Trade Representative. America’s farmers, ranchers, processors, exporters and food manufacturers are foundational in the strength of our country – not just in rural areas, but in feeding, fueling and clothing people in America’s cities and around the world. Key to the economic viability of our working farmers and ranchers is a fair income, and key to their income is the need to export approximately 20 percent of overall U.S. agricultural production. Our farmers, ranchers, processors, exporters and food manufacturers are the reason that American agriculture is one of the most export competitive sectors in the United States and the world. The agriculture and food sector is also critical to American jobs and made-in-America production, ranking as one of the largest U.S. manufacturing sectors, and directly supporting nearly 20 million jobs – the equivalent of more than 13 percent of U.S. employment.1 These jobs provide economic opportunity in rural communities but also for workers throughout the supply chain producing and distributing food and agriculture goods across the country. We are also increasingly focused on achieving critical environmental sustainability and climate goals, building on the work our sector has already accomplished and continues to invest in. Because of the pressing importance of improved and expanded market access for U.S. food and agriculture we request that you move swiftly to nominate an individual to serve as the Chief Agricultural Negotiator at the Office of the U.S. Trade Representative . The farmers, ranchers, processors, exporters and food manufacturing workers we represent rely on the Chief Agriculture Negotiator to be a vigorous advocate for all U.S. agricultural interests and for the role that well-crafted trade policy can play in opening foreign doors to…
Read More

Congress questions logic of vaccine patent waiver
Share
Good Day BIO Newsletter  •  May 17, 2021
Starting a new week with the latest news on the TRIPS waiver—including what Members of Congress said about it—plus a look at bioengineered fashion and a busy Monday on the Hill. (832 words, 4 minutes, 9 seconds)
Read More

Mexico, China, and the future of biotech trade
Share
Good Day BIO Newsletter  •  May 14, 2021
A recap of this week’s hearings on the Biden administration’s trade policy agenda, words of wisdom from Dr. Michelle on how to address vaccine hesitancy among communities of color, and a lot of news. (960 words, 4 minutes, 40 seconds)
Read More

BIO Joins Letter Supporting Endless Frontier Act
Share
Agriculture & Environment  •  Letters, Testimony & Comments  •  May 13, 2021
The undersigned trade associations and private sector organizations write to express our strong support for the Endless Frontier Act, sponsored by Senate Majority Chuck Schumer (D-NY) and Senator Todd Young (R-IN), which would provide much needed, and long overdue, investment in technology, entrepreneurship, science, research and development, and will promote the long-term, global economic competitiveness of the United States. We are encouraged by this bold and visionary bipartisan effort to ensure the U.S. can out-compete our foreign competitors, especially China. We encourage Congress to make passage of this bill a top priority as we move into a period of economic recovery and job growth post-COVID.
Read More

Who develops medicines?
Share
Good Day BIO Newsletter  •  May 13, 2021
We have details on a new study about who really funds FDA-approved medicines, and a bill making its way through the Senate that would boost R&D and the bioeconomy. We’re also watching a House Ways & Means Committee hearing with USTR; we’ll have more on that tomorrow. (716 words, 3 minutes, 34 seconds)
Read More

BIO Joins Letter to President Biden Urging the Need for U.S. Leadership in Global Vaccinations
Share
Vaccines  •  Letters, Testimony & Comments  •  May 12, 2021
Dr. Michelle McMurry-Heath, along with a group of business and policy leaders, sends an open letter to President Biden urging him "to demonstrate decisive U.S. leadership" to combat COVID-19 in Latin America, Europe, Asia, and Africa. 
Read More

Price controls, patent waivers, and Mexico's biotech policies
Share
Good Day BIO Newsletter  •  May 12, 2021
Ahead of congressional hearings today and tomorrow on the Biden administration’s trade policy agenda, we’re unpacking two critical global trade issues: IP protections for COVID-19 vaccines and Mexico’s response to gene-edited agricultural products, specifically corn. (892 words, 4 minutes, 27 seconds)
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 180
  • 181
  • 182
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO